Literature DB >> 19956492

Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with rectal cancer.

In Ja Park1, Hee Cheol Kim, Chang Sik Yu, Choung Soo Kim, Jung Sun Kim, Jin Cheon Kim.   

Abstract

Lymph node involvement is the most important prognostic factor of rectal cancer. Cancer originating from sites other than the rectum rarely metastasizes to the mesorectal lymph node. We report a rectal cancer patient with a synchronous metastatic prostatic carcinoma to the mesorectal lymph node.

Entities:  

Keywords:  Lymph node; Mesorectal; Prostatic carcinoma

Year:  2005        PMID： 19956492      PMCID： PMC2785395          DOI： 10.4143/crt.2005.37.2.129

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN： 1598-2998            Impact factor:   4.679


  9 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum.

Authors:  M W STEARNS; M R DEDDISH
Journal:  Dis Colon Rectum       Date:  1959 Mar-Apr       Impact factor: 4.585

3.  Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.

Authors:  Najat Mourra; Yann Parc; Deborah McNamara; Emmanuel Tiret; Jean-Francois Flejou; Rolland Parc
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

4.  Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection.

Authors:  Y Moriya; K Hojo; T Sawada; Y Koyama
Journal:  Dis Colon Rectum       Date:  1989-04       Impact factor: 4.585

5.  Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma.

Authors:  E E May; E Perentes
Journal:  Histopathology       Date:  1987-03       Impact factor: 5.087

6.  Prostate-specific antigen.

Authors:  E Herman; E Elfont; T Boenisch
Journal:  Histopathology       Date:  1988-06       Impact factor: 5.087

7.  The lymphatics of the prostate.

Authors:  M J Smith
Journal:  Invest Urol       Date:  1966-03

8.  Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases.

Authors:  A P McLaughlin; S L Saltzstein; D L McCullough; R F Gittes
Journal:  J Urol       Date:  1976-01       Impact factor: 7.450

9.  Metastatic prostatic carcinoma presenting as left-sided cervical lymphadenopathy: a series of 11 cases.

Authors:  H Jones; P P Anthony
Journal:  Histopathology       Date:  1992-08       Impact factor: 5.087
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.